FDA
-
-
-
-
-
-
-
Corbus Pharmaceuticals names Brent Pfeiffenberger to board of directors
-
-
-
-
-
-
-
Corbus Pharmaceuticals Announces Broad Alignment with FDA on Registration Path for CRB-701 in Second-Line HNSCC and Cervical Cancer
-
-
-
-
-
-
-
Corbus Pharmaceuticals to Present CRB-701 Phase 1/2 Data at ESMO 2025
-
-
-
-
-
-
-
Corbus Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides a Corporate Update
-
-
-
-
-
-
-
Corbus Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate Update
-
-
-
-
-
-
-
Corbus Pharmaceuticals Announces FDA Clearance of IND Application for its anti-αvβ8 monoclonal antibody (CRB-601)
-
-
-
-
-
-
-
Corbus Pharmaceuticals expands oncology pipeline with the addition of a clinical stage Nectin-4 targeting Antibody Drug Conjugate (ADC)
-
326,686 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

